Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IEC 2021 | Upcoming clinical trials for small molecules to treat autism spectrum disorder

James Clement • 20 Aug 2021
IEC 2021
General

James Clement, PhD, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India, talks on upcoming clinical trials in a compound that can restore the brain function to that of a healthy mouse when given after the brain is developed in autism spectrum disorder treatment. Dr Clement highlights the importance of this finding, as not many other compounds have restored brain function in a developed brain. This interview took place during the 34th International Epilepsy Congress, 2021.

More from James Clement

The next steps in autism treatment: gene therapy
0:46
The next steps in autism treatment: gene therapy
James Clement • 20 Aug 2021
GABAergic signaling in autism spectrum disorders
1:56
GABAergic signaling in autism spectrum disorders
James Clement • 20 Aug 2021
GABA suppressing drugs in epilepsy treatment
0:49
GABA suppressing drugs in epilepsy treatment
James Clement • 20 Aug 2021

Related Videos

A discussion at EAN 2026 on the impact of climate change on neurological diseases
13:26
A discussion at EAN 2026 on the impact of climate change on neurological diseases
Amalia Ghergu et al. • 28 Jun 2026
Medically assisted dying and palliative care in neurological disorders
1:39
Medically assisted dying and palliative care in neurological disorders
Katarina Rukavina • 20 Apr 2026
Skin biopsy in long COVID: LCCS study findings on neuropathy and persistent anosmia
2:42
Skin biopsy in long COVID: LCCS study findings on neuropathy and persistent anosmia
Christopher Gibbons • 21 Apr 2026
Using VJNeurology to stay updated with research advances
0:38
Using VJNeurology to stay updated with research advances
Ana Catarina Fonseca • 5 Feb 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals